LRP1 and infection: Here, primary neurons were pre-treated with recombinant mRAPD3 or a mutated version of mRAPD3 containing K265A/K279E mutations (A/E mutant), which reduces affinity for Lrp1 (15, 37), followed by infection with JCV (MOI = 0.1).